NCT06551298View on ClinicalTrials.gov

Multi Center Clinical Study on the Lipid-lowering Efficacy and Safety of Menggongzi Tibetan Tea Special Drink

NANot yet recruitingINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

August 8, 2025

Study Completion Date

August 8, 2025

Conditions
Hyperlipidemias
Interventions
OTHER

Menggongzi Tibetan Tea Special Drink

Menggongzi Tibetan Tea Special Drink (50ml/time, taken after breakfast and lunch)+Low fat diet

DRUG

Atorvastatin Calcium 20Mg Tab

Atorvastatin Calcium Tablets (20mg, qn)+Low Fat Diet

OTHER

Low fat diet

Low fat diet

Trial Locations (1)

210000

First Affiliated Hospital of Nanjing Medical University, Nanjing

All Listed Sponsors
lead

The First Affiliated Hospital with Nanjing Medical University

OTHER